2021 InvestorPlace Media, LLC. For one thing, Novavax's market cap of around $8 billion is … Every crisis presents an opportunity. The stock market recovery from the COVID-19 crisis was almost as unprecedented as the February-March sell-off. There aren't many smarter investors alive than Warren Buffett. The COVID-resilient growth stocks that … J&J's vaccine has a couple of major advantages. Caterpillar remained profitable in 2020, which allowed it to return “$3.4 billion to shareholders through dividends and share repurchases.”. Even better, Novavax has another great candidate that's likely to win regulatory approvals. Because its services are directly tied to economic strength. According to some Wall Street pros, these new technologies represent a possible inflection point in the war against COVID-19, and could even help drive the stock market’s recovery. The U.S. will have enough COVID-19 vaccine for every American adult by the end of May, President Joe Biden said on Tuesday after Merck & Co agreed to make rival Johnson & Johnson’s inoculation. ... As the COVID-19 vaccinations continue to roll out and the White-House-backed huge … CAE Inc. (TSX:CAE)(NYSE:CAE) and Air Canada (TSX:AC) are two top COVID-19 recovery plays that have still yet to fully rebound. With strong forecasted earnings growth in the coming years, I see Caterpillar’s dividend as very safe. He oversees all content for Sure Dividend and its partner sites. The final name on this list of dividend stocks is far less cyclical than the first two. Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. Here we choose five technology stocks that are well poised to grow as the economy partially reopens. Finally, though, WM stock’s dividend looks very safe, with a payout ratio of just 48.7%. I think that Novavax (NASDAQ:NVAX) ranks as one of the best COVID vaccine stocks on this front. It provides a full suite of waste disposal services, recycling services and a variety of eco-friendly initiatives, like gas-to-energy landfills. Perhaps most importantly, it requires only a single dose. The company’s ability to provide an increasing dividend stream to shareholders is proving very valuable to shareholders, particularly given the experiences in 2020 with some of the individual stocks that were relied upon for income by investors having to suspend or cut dividends. ET Three takeaways. Nasdaq I think that Novavax (NASDAQ:NVAX) ranks as one of the best COVID vaccine stocks on this front. It may be a good time to think internationally as global economic recovery is … But BNT162b2 is just one of many growth drivers for Pfizer. This pandemic has presented the global economy with an unprecedented challenge. Bearing this in mind, we used TipRanks’ database to get more information on three biotech penny stocks, trading for less than $5 per share, that are poised for COVID-related gains. As Covid-19 cases surge in many parts of the world, at least two vaccines are nearing release and the record-setting stock market seems willing to look ahead to a global recovery. Smart investors seek really good risk-reward propositions with the stocks they buy. Even better, they all pay dividends and have higher yields than the broader market. What Is the IPO Price Range? Bob Ciura has worked at Sure Dividend since 2016. Prior to joining Sure Dividend, Bob was an independent equity analyst. Some alternatives are better than others, though. After all, a strong economy means goods need to be moved around. "The stocks on my Go list are screaming, despite the skyrocketing [Covid-19] case count," the "Mad Money" host said, adding that the country will start beating the virus in a "couple months." Pfizer thinks that it will be able to generate annual adjusted earnings-per-share growth of around 10% over the next five years. What Are the Best COVID Vaccine Stocks for Conservative and Aggressive Investors? Unsurprisingly, CAT is also on the Dividend Aristocrats list, a group in the S&P 500 with 25-plus consecutive years of dividend growth. The same is true for when the economy weakens — demand for UPS’s services declines significantly. Novavax Is Preselling Its Coronavirus Vaccine, but at What Price? Copyright © Questioning an investing thesis -- even one of our own -- helps us all think critically about investing and make decisions that help us become smarter, happier, and richer. Vaccine Market, These 2 Elements in Novavax's Earnings Report Could Mean Billions for the Biotech. quotes delayed at least 15 minutes, all others at least 20 minutes. There is also room to continue raising the payout in the future. These 2 Companies May Be the Next to Enter the U.S. All told, these names have safe payouts and will benefit greatly from the recovery coming in 2021 and beyond. Right now, the company trades with a market capitalization of $139 billion and is projected to generate about $87.5 billion in annual revenue this year. Article printed from InvestorPlace Media, https://investorplace.com/2021/03/3-dividend-stocks-for-a-2021-economic-recovery/. This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. Many stocks have recovered, however, in the year since the Covid-19 crisis broke. It should produce about $46.3 billion in revenue in 2021. We’re motley! In addition to that, it maintains a safe dividend. Tech stocks lead the way to COVID-19 recovery. Here are three COVID vaccine stocks that smart investors are buying for 2021. Returns as of 03/08/2021. Even in 2020, however — a terrible year for the world’s economy — UPS still managed to generate record sales and adjusted earnings-per-share (EPS). One example would be construction debris — if the economy is weak, construction activity slows and there’s less waste. Monday Jan 25, 2021 . In particular, mining and construction are two of the most cyclical sectors of the economy, making CAT a major beneficiary in 2021. Plus, construction universally tends to rely upon perceived economic strength from developers. J&J is also making its vaccine available at cost during the pandemic. With the company's solid dividend (which currently yields more than 4%) thrown in, the stock should be in a great position to deliver market-beating returns. All of the other leading COVID vaccines require two doses. Should Novavax bring both NVX-Cov2373 and NanoFlu to market, I wouldn't be surprised for its shares to double or more. Source: Sundry Photography / Shutterstock.com, 3 Dividend Stocks for a 2021 Economic Recovery, When Does Roblox Go Public? International stocks post-Covid. His articles have been published on major financial websites such as The Motley Fool, Seeking Alpha, Business Insider and more. If all goes well, the vaccine could win emergency use authorization (EUA) and be on the U.S. market in February. Waste Management is the largest waste management company in North America. Copyright © 2021 InvestorPlace Media, LLC. The company's size and diversification give it a rock-solid stability that no other vaccine maker can touch. UPS will be a major beneficiary of the incoming economic recovery. URL Copied; An Emirati trader passes under the stocks display screen at … 8 out of 10 people are expected to be affected by COVID-19. However, 2021 could very well be viewed as the year of the COVID-19 vaccine. Blood thinner Eliquis, cancer drugs Ibrance and Xtandi, autoimmune disease drug Xeljanz, and rare disease drug Vynaqel stand at the top of the list. Inversely, if the economy is booming, developers will spend more on new projects. Caterpillar is a heavy-equipment manufacturer that is thoroughly involved in global construction and mining markets. For example, these picks are all held in the Bill Gates Foundation’s portfolio. Bob received a bachelor’s degree in Finance from DePaul University and an MBA with a concentration in investments from the University of Notre Dame. That means there’s ample room for a decline in earnings without undue stress on the dividend. Cramer, who crafted the Cramer Covid-19 Index of 100 stocks he projected would benefit from the lockdown environment, signaled that he's warming up to the economic recovery … Given that CAT is leveraged to such a cyclical market, it’s also extraordinary that the company has been able to raise its dividend for 26 consecutive years. EIA sees energy demand recovery from COVID-19 as soon as 2029 ... She has spent the bulk of her years at the company writing the daily Futures Movers and Metals Stocks … The market's swift recovery over the last three months has pushed a lot of stocks higher year to date, despite the continuing COVID-19 pandemic and the … At least one analyst thinks that NanoFlu could generate peak annual sales of up to $1.7 billion if approved. The company reported overwhelmingly positive results from a late-stage study of experimental flu vaccine NanoFlu earlier this year. All rights reserved. So, we should see more upside ahead. Indeed, only two stocks in … Of course, as a major industrial manufacturer with customers in multiple industries, CAT is highly leveraged to economic growth. That made the healthcare giant the top COVID vaccine stock for hedge fund managers. Coronavirus: Global stocks rise on recovery hopes. I think other investors won't go wrong by following the lead of the Oracle of Omaha in this case. COVID-19 has been a nightmare for almost every stock in the market, but not for Regeneron Pharmaceuticals (REGN, $444.57). 7 Reopening and Recovery Stocks Analysts Want You to Buy Now. Americans may be itching to travel again now that more people are getting vaccinated for Covid-19 — and there are several stocks poised to benefit as … Stocks Say Covid Recovery Is Nigh. On the date of publication, Bob Ciura held a long position in UPS. Save. Reuters. So, Caterpillar’s ability to raise its dividend each year — even during downturns — makes it a critical entry among dividend stocks. Right now, it’s net income margin currently sits at a healthy 9.83%. Right now, CAT stock trades with a market cap of $117.6 billion. All rights reserved. The company expects to announce interim efficacy results from a large late-stage study in January. Cumulative Growth of a $10,000 Investment in Stock Advisor, 3 COVID Vaccine Stocks Smart Investors Are Buying for 2021 @themotleyfool #stocks $NVAX $PFE $JNJ $BRKA $BRKB $BNTX, safest bet of all among COVID vaccine stocks.